Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
about
Recent Advances in the Diagnosis and Treatment of Clostridium Difficile InfectionUltrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile InfectionWSES guidelines for management of Clostridium difficile infection in surgical patientsLaboratory diagnosis of bacterial gastroenteritisDiagnosis of Clostridium difficile Infections in ChildrenRole of cephalosporins in the era of Clostridium difficile infectionAsymptomatic Clostridium difficile colonization: epidemiology and clinical implicationsAsymptomatic Clostridium difficile colonisation and onward transmissionConventional and alternative treatment approaches for Clostridium difficile infectionClostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.Clostridium difficile infection: guideline-based diagnosis and treatmentRibotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortalityEfficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene.Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study.Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficilePoint-of-Care Testing for Clostridium Difficile Infection: A Real-World Feasibility Study of a Rapid Molecular Test in Two Hospital Settings.Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis.Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies.Comparison of the Vidas C. difficile GDH Automated Enzyme-Linked Fluorescence Immunoassay (ELFA) with Another Commercial Enzyme Immunoassay (EIA) (Quik Chek-60), Two Selective Media, and a PCR Assay for gluD for Detection of Clostridium difficile inStructural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortalityDevelopment and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in StoolComparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in KoreaFalse Negative Results in Clostridium difficile Testing.Growth Patterns of Clostridium difficile - Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study.Usefulness of Adjunctive Fecal Calprotectin and Serum Procalcitonin in Individuals Positive for Clostridium difficile Toxin Gene by PCR Assay.Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study.NAP1 strain type predicts outcomes from Clostridium difficile infection.Persisting variation in testing and reporting Clostridium difficile cases.Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.A low complexity rapid molecular method for detection of Clostridium difficile in stool.Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID)A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool.Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation.
P2860
Q26766112-EEAD8E51-E55E-4B1A-822A-709B912D0BFDQ26776411-31D0D843-2BFF-4365-9172-3FFAF6A90FDEQ26795429-8B994217-8434-4751-AF71-7A24A43F88F2Q27027754-011AD50F-6075-4B9D-A873-41C2F20A1B7EQ28075324-536096F9-AF7D-41B9-A212-258070102016Q28078261-6A2C7454-83E8-4C70-8CE4-79B0B4B66B55Q28083860-4663F0E9-87AF-41D9-97E9-AEBBEEC5D4E3Q28661623-37870D63-1C1B-4545-8D77-30E37A7E28F0Q30235278-85180867-C54C-4708-BA0D-01086B2767E1Q30235905-A14B08D8-5F1C-4048-8945-43184EAC5E54Q30316981-07BD8FC4-75E3-4070-B8B1-48BF4B9CDE26Q30413111-D1D939B5-CC87-459F-8EDC-282BF6DFCF49Q33831557-5DF5D5B1-38E0-436B-B111-90516D9D3FB9Q33900174-F94A921A-5BF7-47C3-9FBF-04D1CDF21FD6Q34110399-60828548-B1C9-4F02-8CB0-26430C16616EQ34419009-26DF7DB4-A0A1-420E-964D-0F4EDD1E7384Q34726112-BF396DF1-86D4-41C5-A943-231BB621965FQ34726271-D58CD6B6-9B56-44CD-9D9C-5D7CB0AEE36CQ35331588-C39E106A-C4A7-456F-8EB5-723BF6574830Q35461796-76CDB49A-E74A-458C-9ABD-93B3154CD73EQ35607512-3AFA0129-D9A1-4FB7-90AC-2C616A165A5FQ36018079-7698391B-CA78-4C9A-AD0F-71D86DBA407EQ36049005-0C50275A-0019-4B6D-89DD-A99CDD53E5CCQ36066827-C1A63175-D831-46DE-9F54-305AC2A7A1ACQ36105550-F2314244-19B3-4507-82C2-E9E5739032E7Q36108285-66548C6B-F7EB-413E-B861-E304EE499897Q36123790-8BEC3BA6-A4B2-47A7-889B-F7C4B68CA828Q36173931-2E476307-8859-44AB-A924-3AAB8BE031F2Q36186012-558B0AF7-DB07-4988-A5A4-C74548CBC807Q36420815-89996C80-B096-4708-8212-63285F6497EFQ36516986-FC412594-C6D3-4305-93DA-E9EAA5A7A5FAQ37103258-B3CAE43C-6F7D-4F38-B8D5-8EEA9E3AD518Q37109212-28943462-5DD0-4A42-AF9F-5DE4B7D58451Q37452494-811F378D-2954-4812-8756-897FE6107223Q37475243-90A264EC-3972-4BDB-9D8B-0752A38E7D75Q37546108-D80E5FAC-F6FC-4104-AC98-2D317BA3CF59Q37546208-320A6CEF-C06E-4385-A244-539881A15BE0Q37713428-4726833D-54AF-4499-8327-374DB48B6611Q38162391-E9D48228-0360-458A-82EA-25ACA8B816E5Q38175865-5F89FB3C-4733-43C0-931F-2F77F0671E3B
P2860
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differences in outcome accordi ...... study of C difficile infection
@en
Differences in outcome accordi ...... tudy of C difficile infection.
@nl
type
label
Differences in outcome accordi ...... study of C difficile infection
@en
Differences in outcome accordi ...... tudy of C difficile infection.
@nl
prefLabel
Differences in outcome accordi ...... study of C difficile infection
@en
Differences in outcome accordi ...... tudy of C difficile infection.
@nl
P2093
P2860
P921
P1154
2-s2.0-84885955622
P1476
Differences in outcome accordi ...... study of C difficile infection
@en
P2093
Cassie F Pope
Derrick W Crook
Irene M Monahan
John M Finney
Kerrie A Davies
Kirsti A Morris
Lily O'Connor
Mike W Wren
Nandini P Shetty
Pietro G Coen
P2860
P304
P356
10.1016/S1473-3099(13)70200-7
P5530
P577
2013-09-03T00:00:00Z
P6179
1012096058